Opus Genetics, Inc. (Nasdaq: IRD) (the "Company” or "Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

In a recent video interview with Applied Clinical Trials, Rob DiCicco, vice president of portfolio management at ...

Researchers receive UK recognition after developing self-calibrating imaging technology that improves precision in healthcare ...

A team of Nigerian scientists has earned international recognition after securing intellectual property protection in the ...

Protocol design does not struggle in the protocol. It struggles in the transition to trial, when assumptions embedded in the ...

Chris Gotterup won the 2026 John Deere Classic on Sunday for his fifth PGA Tour win. Here's a breakdown of what's in his ...

An institution under attack from the Trump administration provided relief from the weather on July 4 — and a chance to ponder ...

Instead of pushing mandates, leaders should build an office that actually delivers on the promise of stronger collaboration ...

A team of Nigerian scientists has secured intellectual property protection in the United Kingdom for a home-grown medical ...

A new laser-optical system uses 2,000 controllable beams to precisely position atoms, enabling key logic processes in a ...

The Oklahoma Turnpike Authority says design work on the 19-mile South Extension Turnpike is progressing ahead of schedule, ...

The vivo X300e sounds a lot like the vivo X300 FE, but with a bigger battery and screen. Vivo has already released a bunch of ...